Correlation Between PetIQ and Enliven Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PetIQ and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PetIQ and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PetIQ Inc and Enliven Therapeutics, you can compare the effects of market volatilities on PetIQ and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PetIQ with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PetIQ and Enliven Therapeutics.

Diversification Opportunities for PetIQ and Enliven Therapeutics

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between PetIQ and Enliven is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding PetIQ Inc and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and PetIQ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PetIQ Inc are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of PetIQ i.e., PetIQ and Enliven Therapeutics go up and down completely randomly.

Pair Corralation between PetIQ and Enliven Therapeutics

Given the investment horizon of 90 days PetIQ Inc is expected to generate 0.78 times more return on investment than Enliven Therapeutics. However, PetIQ Inc is 1.28 times less risky than Enliven Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.04 per unit of risk. If you would invest  766.00  in PetIQ Inc on July 13, 2024 and sell it today you would earn a total of  2,323  from holding PetIQ Inc or generate 303.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

PetIQ Inc  vs.  Enliven Therapeutics

 Performance 
       Timeline  
PetIQ Inc 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in PetIQ Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, PetIQ reported solid returns over the last few months and may actually be approaching a breakup point.
Enliven Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in November 2024.

PetIQ and Enliven Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PetIQ and Enliven Therapeutics

The main advantage of trading using opposite PetIQ and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PetIQ position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.
The idea behind PetIQ Inc and Enliven Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk